Top Markets
Coin of the day
NAYA Biosciences, Inc. NAYA Biosciences, Inc.

NAYA Biosciences, Inc.

NAYA
Rank in Stocks #33841
INVO Bioscience operates as a medical device company, focusing on the... INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility. Their primary innovation is INVOcell, a unique reproductive technology designed to allow both fertilization and the early development of an embryo to happen inside the woman's own body.
Share Price
$1.78
Last synced: 2025-05-22
Market Cap
$6.77M
Change (1 day)
-9.18%
Change (1 year)
0.00%
Country
US
Trade NAYA Biosciences, Inc. (NAYA)

Category

Operating Margin for NAYA Biosciences, Inc. (NAYA)
Operating Margin as of August 2026 TTM: -124.40%
According to NAYA Biosciences, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is -124.40%. At the end of 2023 the company had an Operating Margin of -224.04%.
Operating Margin history for NAYA Biosciences, Inc. from 2006 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -124.40% 0.00%
2024 -124.40% -44.47%
2023 -224.04% -82.67%
2022 -1,292.45% 930.74%
2021 -125.39% -76.42%
2020 -531.67% 340.12%
2019 -120.80% -77.33%
2018 -532.81% 134.74%
2017 -226.98% -94.53%
2016 -4,146.12% -18.56%
2015 -5,090.89% 127.26%
2010 -2,240.10% -23.17%
2009 -2,915.59% -40.49%
2008 -4,899.22% 0.00%
2007 0.00% 0.00%
2006 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
17.03% -100.14%
US
22.03% -100.18%
US
17.86% -100.14%
IE
21.46% -100.17%
US
28.09% -100.23%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.